Speaker/Presentation

Time in CEST

Chair Introduction

Motowo Nakajima

9:00 am – 9:10 am

5-ALA-XDT opportunities in cancer therapy

Andrea Ebeling

9:10 am– 9:30 am

Systemic Consequences of 5-ALA Synthase 1 (Alas1) gene Disruption and the Protective Role of 5-ALA

Osamu Nakajima

9:30 am– 9:50 am

5-ALA therapy for mitochondrial diseases
Akira Ohtake

9:50 am– 10:10 am

Q&A

10:10 am– 10:25 am

Closing of Webinar

Motowo Nakajima

10:25 am– 10:30 am